Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: Final baseline characteristics of the IMPROVE-IT study population

Published 2014 View Full Article

Authors

Keywords

Journal

AMERICAN HEART JOURNAL

Volume 168, Issue 2, Pages 205-212.e1

Publisher

Elsevier BV

Online

2014-05-15

DOI

10.1016/j.ahj.2014.05.004

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

AMERICAN HEART JOURNAL

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Create your own webinar

Ask a Question. Answer a Question.